Genenta Science S.p.A. (GNTA) Form 6-K — Jul 14, 2026

The Court of Milan has revoked a preliminary order that suspended the effectiveness of a corporate purpose amendment to Article 4 of Genenta Science's bylaws. The ruling, dated July 9, 2026, grants the company's appeal and immediately restores the amendment approved by shareholders on October 29, 2025. The court determined that Genenta's interest in maintaining the amendment outweighs the alleged prejudice claimed by the plaintiffs, noting the significant investments already made and the importance of avoiding a strategic impasse.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.